Aristo Bio-Tech IPO vs Rex Sealing IPO

Comparison between Aristo Bio-Tech IPO and Rex Sealing IPO.

IPO Details

Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Rex Sealing IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the Rex Sealing IPO is up to ₹7.64 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of Rex Sealing IPO is ₹135.00 per share.

 Aristo Bio-Tech IPORex Sealing IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹72.00 per share₹135.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares1000 shares
Fresh Issue Size17,21,600 shares2,67,000 shares
Fresh Issue Size (Amount)up to ₹12.40 Crup to ₹3.60 Cr
OFS Issue Size0 shares2,99,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹4.04 Cr
Issue Size Total17,21,600 shares5,66,000 shares
Issue Size Total (Amount)up to ₹12.40 Crup to ₹7.64 Cr

IPO Timetable

Aristo Bio-Tech IPO opens on Jan 16, 2023, while Rex Sealing IPO opens on Dec 30, 2022. The closing date of Aristo Bio-Tech IPO and Rex Sealing IPO is Jan 19, 2023, and Jan 04, 2023, respectively.

 Aristo Bio-Tech IPORex Sealing IPO
Issue OpenJan 16, 2023Dec 30, 2022
Issue CloseJan 19, 2023Jan 04, 2023
Basis Of Allotment (Tentative)Jan 24, 2023Jan 09, 2023
Initiation of Refunds (Tentative)Jan 25, 2023Jan 10, 2023
Credit of Share (Tentative)Jan 27, 2023Jan 11, 2023
Listing date (Tentative)Jan 30, 2023Jan 12, 2023

Financials & KPIs

Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to Rex Sealing IPO P/E ratio of 19.62.

 Aristo Bio-Tech IPORex Sealing IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets108.6977.0081.4287.85
Total Income129.07166.03167.23201.24
Profit After Tax2.591.461.081.01
NET Worth17.4314.8413.3812.31
Reserves and Surplus12.449.858.397.31
Total Borrowing29.3625.4822.2519.71
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Jun 202231 Mar 202231 Mar 202131 Mar 2020
Assets15.0914.4413.1713.57
Total Income5.7221.1617.2620.18
Profit After Tax0.380.550.371.13
NET Worth8.628.247.707.33
Reserves and Surplus0.000.000.000.00
Total Borrowing3.283.783.394.37
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%99.99%
Promoter Shareholding (Post-Issue)73.37%73.02%
P/E Ratio9.4619.62
Market Cap₹49.02 Cr.₹29.97 Cr.
ROE29.2648.77
ROCE35.646.77
Debt/Equity5.100.46
EPS₹2.93₹2.85
RoNW106.63

Shares Offered

In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in Rex Sealing IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and 0 shares in Rex Sealing IPO.

 Aristo Bio-Tech IPORex Sealing IPO
Anchor Investor Reservation0 shares
Market Maker Reservation91,200 shares33,000 shares
QIB0 shares
NII8,60,800 shares2,83,000 shares
RII8,60,800 shares2,83,000 shares
Employee0 shares
Total17,21,600 shares5,66,000 shares

Bids Received (Subscription)

Aristo Bio-Tech IPO subscribed 217.72x in total, whereas Rex Sealing IPO subscribed 2.65x.

 Aristo Bio-Tech IPORex Sealing IPO
NII (times)285.84x2.00x
RII (times)149.59x3.30x
Total (times)217.72x2.65x

Compare with others

Compare: